Annular erythema in primary Sjögren’s syndrome: description of 43 non-Asian cases

Lupus - Tập 23 Số 2 - Trang 166-175 - 2014
Pilar Brito‐Zerón1, Soledad Retamozo1, Miriam Akasbi2,1, Myriam Gandía3, M. Pérez-de-Lis4, M.J. Soto Cárdenas3, Cándido Díaz‐Lagares1, Belchin Kostov5, Albert Selva-O’Callaghan1, Xavier Bosch6, R. Pérez-Álvarez4, Antoni Xaubet5, Manuel Ramos‐Casals1
1Sjögren Syndrome Research Group (AGAUR), Laboratory of Autoimmune Diseases Josep Font-CELLEX, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Department of Autoimmune Diseases
2Department of Internal Medicine, Hospital Infanta Leonor, Spain
3Department of Internal Medicine, University of Cadiz, Hospital Puerta del Mar, Spain
4Department of Internal Medicine, Hospital do Meixoeiro, Spain
5Primary Care Research Group, IDIBAPS, Centre d’Assistència Primària ABS Les Corts, GESCLINIC, Spain
6Department of Internal Medicine, ICMiD, Spain

Tóm tắt

Objective The objective of this paper is to evaluate the prevalence and characterize the main epidemiological, clinical and immunological features of annular erythema (AE) in non-Asian patients with primary Sjögren’s syndrome (SS). Methods We carried out a retrospective study searching for AE in 377 Spanish patients with primary SS fulfilling the 2002 American-European criteria. In addition, we searched PubMed (1994–2012) using the MeSH terms “annular erythema” and “primary Sjögren’s syndrome” for additional cases. All cases with AE reported in patients with SS associated with systemic lupus erythematosus were excluded. Results In our Spanish cohort, we found 35 (9%) patients diagnosed with AE. All were white females, with a mean age of 47 years at diagnosis of AE. AE preceded diagnosis of SS in 27 (77%) patients. Cutaneous AE lesions involved principally the face and upper extremities. All patients reported photosensitivity, with cutaneous flares being reported during the warmest months in 93% of patients. Immunological markers consisted of anti-Ro/La antibodies in 31 (89%) patients. In the literature search, we identified eight additional non-Asian patients with primary SS diagnosed with AE. In comparison with 52 Asian patients, the 43 non-Asian patients with AE related to primary SS were more frequently women (100% vs 78%, p = 0.008), and cutaneous lesions were less frequently reported in the face (55% vs 81%, p = 0.045) and more frequently in the neck (40% vs 14%, p = 0.041). Immunologically, non-Asian patients had a lower frequency of anti-Ro antibodies and a higher frequency of negative Ro/La antibodies, although the differences were not statistically significant. Conclusion AE is not an exclusive cutaneous feature of Asian patients with primary SS. In addition to the characteristic cutaneous expression, AE has a very specific clinical and immunological profile: often presenting before the fulfillment of SS criteria, overwhelmingly associated with anti-Ro antibodies but weakly associated with other immunological markers and the main systemic SS-related features.

Từ khóa


Tài liệu tham khảo

10.1136/bmj.e3821

10.1001/archinte.164.12.1275

10.1097/MD.0b013e318181e6af

10.1097/01.md.0000119465.24818.98

Walling HW, 2012, Sjögren’s syndrome: Diagnosis and therapeutics, 157

10.1007/978-0-85729-358-9_5

10.1016/S0190-9622(89)70070-0

10.1111/j.1365-4362.1991.tb03489.x

10.1136/ard.61.6.554

Hsu S, 2001, Am Fam Physician, 64, 289

10.1136/ard.2009.110619

10.1136/annrheumdis-2011-200766

10.3109/s10165-009-0257-y

10.1177/096120339400300114

Usuda T, 1995, Nihon Rinsho, 53, 2557

10.1016/S0190-9622(97)70283-4

Yamamoto T, 1998, Eur J Dermatol, 8, 248

10.1111/j.1346-8138.1998.tb02374.x

10.1046/j.1365-2133.1999.02623.x

10.1067/mjd.2000.105508

10.3346/jkms.2000.15.1.115

10.1007/s001050051118

10.3346/jkms.2000.15.2.199

10.1111/j.1346-8138.2001.tb00086.x

10.1046/j.1365-2133.2002.04995.x

Bernacchi E, 2004, Clin Exp Rheumatol, 22, 55

10.1111/j.1365-2230.2005.01803.x

10.1016/S0140-6736(06)68698-4

10.1007/s00296-008-0794-2

10.1007/s10067-006-0374-3

10.1111/j.1346-8138.2010.00926.x

Owczarek W, 2010, Pol Merkur Lekarski, 28, 126

10.1002/art.1780360309

10.1111/j.1365-2133.2009.09472.x

10.1016/j.semarthrit.2006.08.007

10.7326/0003-4819-97-5-664

10.1001/archderm.138.9.1175

10.1016/j.autrev.2012.08.019

Lowe G, 2011, Br J Dermatol, 164, 465

10.1097/BOR.0b013e32835b1366

Retamozo S, 2012, Clin Exp Rheumatol, 30, 686

10.1111/j.1365-2133.1992.tb14874.x

10.1111/j.1749-6632.2009.04676.x

10.1016/0190-9622(93)70025-O

10.1016/S0190-9622(86)70295-8

10.3346/jkms.2000.15.2.199

10.1016/j.autrev.2004.10.003

10.1016/j.autrev.2008.12.017

10.1001/archderm.1996.03890290062008